🔗 Share this article

A shadow economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a flourishing market exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of rapid British shipping. Vendors market the substance there before redirecting buyers to WhatsApp for purchases.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the UK is worrisome and could lead to users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach medicines, marketing, and consumer regulations, risking fines, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the service has taken down problematic content and prohibited related keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at home.

After moments of entering one community, a vendor shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, health issues or past usage.

Item Details and Pricing

Within these groups, posts show dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, mixed at residence with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how much time a pen should last, sellers give conflicting answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are administering substances they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But counterfeit injections are highly risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she said.

Her team has already encountered individuals harmed by personal administration from unconfirmed suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially serious medical dangers”.